Simon J. Shaw

10.0k total citations · 3 hit papers
55 papers, 5.9k citations indexed

About

Simon J. Shaw is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Simon J. Shaw has authored 55 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 19 papers in Organic Chemistry and 14 papers in Pharmacology. Recurrent topics in Simon J. Shaw's work include Microbial Natural Products and Biosynthesis (10 papers), Cancer Treatment and Pharmacology (8 papers) and Synthetic Organic Chemistry Methods (6 papers). Simon J. Shaw is often cited by papers focused on Microbial Natural Products and Biosynthesis (10 papers), Cancer Treatment and Pharmacology (8 papers) and Synthetic Organic Chemistry Methods (6 papers). Simon J. Shaw collaborates with scholars based in United States, Denmark and Netherlands. Simon J. Shaw's co-authors include Tilmann Weber, Kai Blin, Marnix H. Medema, Gilles P. van Wezel, Kat Steinke, Nadine Ziemert, Sang Yup Lee, Alexander Kloosterman, Zachary Charlop–Powers and Hannah E. Augustijn and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Simon J. Shaw

51 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline

2019 2.2k citations Kai Blin, Simon J. Shaw et al. Nucleic Acids Research profile →
antiSMASH 6.0: improving cluster detection and comparison capabilities

2021 1.8k citations Kai Blin, Simon J. Shaw et al. Nucleic Acids Research profile →
antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation

2023 1.1k citations Kai Blin, Simon J. Shaw et al. Nucleic Acids Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon J. Shaw United States	17	3.8k	2.3k	1.5k	1.1k	986	55	5.9k
Joachim Vater Germany	41	4.0k 1.0×	1.4k 0.6×	2.7k 1.8×	864 0.8×	743 0.8×	117	7.0k
Nadine Ziemert Germany	33	4.3k 1.1×	3.5k 1.5×	1.0k 0.7×	1.1k 1.0×	1.3k 1.3×	63	6.1k
Liangcheng Du United States	39	2.6k 0.7×	2.2k 1.0×	1.4k 1.0×	354 0.3×	842 0.9×	110	4.5k
Olga Genilloud Spain	37	2.5k 0.7×	2.7k 1.2×	856 0.6×	527 0.5×	1.1k 1.1×	200	5.2k
Eriko Takano United Kingdom	45	7.8k 2.0×	6.0k 2.6×	2.0k 1.3×	1.1k 0.9×	1.9k 1.9×	128	10.8k
Kozo Ochi Japan	47	4.8k 1.2×	3.0k 1.3×	986 0.7×	1.0k 0.9×	989 1.0×	179	6.9k
Wensheng Xiang China	34	2.9k 0.7×	1.7k 0.7×	1.8k 1.2×	550 0.5×	566 0.6×	403	5.2k
Sean F. Brady United States	53	6.0k 1.6×	3.6k 1.5×	733 0.5×	1.8k 1.6×	1.5k 1.5×	134	8.9k
William C. Nierman United States	53	3.8k 1.0×	1.7k 0.7×	3.1k 2.1×	669 0.6×	434 0.4×	142	8.0k
David P. Labeda United States	36	2.4k 0.6×	1.4k 0.6×	1.2k 0.8×	657 0.6×	487 0.5×	99	3.8k

Countries citing papers authored by Simon J. Shaw

Since Specialization

Citations

This map shows the geographic impact of Simon J. Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon J. Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon J. Shaw more than expected).

Fields of papers citing papers by Simon J. Shaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon J. Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon J. Shaw. The network helps show where Simon J. Shaw may publish in the future.

Co-authorship network of co-authors of Simon J. Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Simon J. Shaw. A scholar is included among the top collaborators of Simon J. Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon J. Shaw. Simon J. Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Booth, Thomas, Simon J. Shaw, Pablo Cruz‐Morales, & Tilmann Weber. (2025). getphylo: rapid and automatic generation of multi-locus phylogenetic trees. BMC Bioinformatics. 26(1). 21–21. 2 indexed citations

Blin, Kai, Simon J. Shaw, Marnix H. Medema, & Tilmann Weber. (2025). The antiSMASH database version 5. Nucleic Acids Research. 54(D1). D522–D526.

Watts, Justin M., Simon J. Shaw, & Brian A. Jonas. (2024). Looking Beyond the Surface: Olutasidenib and Ivosidenib for Treatment of mIDH1 Acute Myeloid Leukemia. Current Treatment Options in Oncology. 25(11). 1345–1353. 7 indexed citations

Blin, Kai, Simon J. Shaw, Hannah E. Augustijn, et al.. (2023). antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation. Nucleic Acids Research. 51(W1). W46–W50. 1116 indexed citations breakdown →

Shaw, Simon J., Dane A. Goff, D. C. Carroll, et al.. (2022). Structure activity relationships leading to the identification of the indirect activator of AMPK, R419. Bioorganic & Medicinal Chemistry. 71. 116951–116951. 2 indexed citations

Blin, Kai, Simon J. Shaw, Satria A. Kautsar, Marnix H. Medema, & Tilmann Weber. (2020). The antiSMASH database version 3: increased taxonomic coverage and new query features for modular enzymes. Nucleic Acids Research. 49(D1). D639–D643. 101 indexed citations

Kautsar, Satria A., Kai Blin, Simon J. Shaw, Tilmann Weber, & Marnix H. Medema. (2020). BiG-FAM: the biosynthetic gene cluster families database. Nucleic Acids Research. 49(D1). D490–D497. 146 indexed citations

Blin, Kai, Simon J. Shaw, Yaojun Tong, & Tilmann Weber. (2020). Designing sgRNAs for CRISPR-BEST base editing applications with CRISPy-web 2.0. Synthetic and Systems Biotechnology. 5(2). 99–102. 20 indexed citations

Yan, Yan, X. Edward Zhou, Scott J. Novick, et al.. (2018). Structures of AMP-activated protein kinase bound to novel pharmacological activators in phosphorylated, non-phosphorylated, and nucleotide-free states. Journal of Biological Chemistry. 294(3). 953–967. 32 indexed citations

10.

Shaw, Simon J., Dane A. Goff, Rajinder Singh, et al.. (2017). Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus. Bioorganic & Medicinal Chemistry Letters. 27(11). 2617–2621. 9 indexed citations

11.

Singh, Rajinder, D. C. Carroll, Jianing Huang, et al.. (2015). Developing structure–activity relationships from an HTS hit for inhibition of the Cks1–Skp2 protein–protein interaction. Bioorganic & Medicinal Chemistry Letters. 25(22). 5199–5202. 25 indexed citations

12.

Koning, Frits, Anjna Badhan, Simon J. Shaw, et al.. (2013). Dynamics of HIV Type 1 Recombination Following Superinfection. AIDS Research and Human Retroviruses. 29(6). 963–970. 16 indexed citations

13.

Liu, Yaoquan, et al.. (2011). The role of the 4′′-hydroxyl on motilin agonist potency in the 9-dihydroerythromycin series. Bioorganic & Medicinal Chemistry Letters. 21(12). 3712–3714. 3 indexed citations

14.

Liu, Yaoquan, et al.. (2010). 9-Dihydroerythromycin ethers as motilin agonists—Developing structure–activity relationships for potency and safety. Bioorganic & Medicinal Chemistry. 18(21). 7651–7658. 4 indexed citations

15.

Tian, Zong‐Qiang, Zhan Wang, David C. Myles, et al.. (2008). Investigating Amine Derivatives of Ambruticin VS‐5 and VS‐4. ChemMedChem. 3(6). 963–969. 4 indexed citations

16.

Shaw, Simon J.. (2008). The Structure Activity Relationship of Discodermolide Analogues. Mini-Reviews in Medicinal Chemistry. 8(3). 276–284. 36 indexed citations

17.

Shaw, Simon J., Hugo G. Menzella, David C. Myles, Ming Xian, & Amos B. Smith. (2007). Coumarin-derived discodermolide analogues possessing equivalent antiproliferative activity to the natural product—a further simplification of the lactone region. Organic & Biomolecular Chemistry. 5(17). 2753–2753. 10 indexed citations

18.

Wang, Zhan, et al.. (2006). Investigating Carboxylic Acid Analogues of Ambruticin through Semi‐Synthesis. ChemMedChem. 1(10). 1063–1065. 6 indexed citations

19.

Shaw, Simon J., Darren Abbanat, Gary W. Ashley, et al.. (2005). 15-Amido Erythromycins: Synthesis and in Vitro Activity of a New Class of Macrolide Antibiotics. The Journal of Antibiotics. 58(3). 167–177. 14 indexed citations

20.

Burlingame, Mark A., Simon J. Shaw, Kurt F. Sundermann, et al.. (2004). Design, synthesis and cytotoxicity of 7-deoxy aryl discodermolide analogues. Bioorganic & Medicinal Chemistry Letters. 14(9). 2335–2338. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact